Please assess the completion status of the following clinical trial:

Trial Title: Effect of Lidocaine and Esmolol to Improve the Quality of Recovery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled to undergo abdominal surgical procedures~* Willingness and ability to sign an informed consent document~* No allergies to anesthetic or analgesic medications~* 18 - 80 years of age~* American Society of Anesthesiologists (ASA) physical status classification: Class I - III adults of either sex~* Women of childbearing potential must be currently practicing an acceptable form of birth control, and have a negative urine or blood pregnancy test~* Patients with systolic blood pressure greater than 80 and less than 150 at baseline, diastolic blood pressure less than 100 at baseline.~Exclusion Criteria:~* Inability to comprehend the pain assessment tools.~* Patients with known allergy, hypersensitivity or contraindications to anesthetic or analgesic medications~* Patients with clinically-significant medical conditions, such as brain, heart, kidney, endocrine, or liver diseases,~* Peptic ulcer disease or bleeding disorders~* Patients with history of hepatic, renal, cardiac failure, organ transplant, or diabetes~* Patients with reactive airway disease (asthma)~* Patients with seizures~* Chronic use of ß-blocker or calcium channel blocker~* Morbid obesity (body mass index \>40)~* Pregnant or lactating women~* Subjects with a history of alcohol or drug abuse within the past 3 months~* Any other conditions or use of any medication which may interfere with the conduct of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction:Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
- Esmolol (Type: ACTIVE_COMPARATOR): Pre-Induction: Loading dose 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
- Lidocaine + Esmolol (Combo) (Type: EXPERIMENTAL): Performed with the administration of both drugs.~Pre-induction:~Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg)~Post-induction:~Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)

Based on this trial design, predict the completion outcome and termination type (if applicable).